Axogen, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 7, 2024).
| Zdroj: | Health & Medicine Week; 11/29/2024, p10308-10308, 1p |
|---|---|
| Abstrakt: | Axogen, Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 7, 2024. The Form 10-Q is a quarterly report that includes unaudited financial statements and provides insight into the company's financial position throughout the year. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article] |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|